Skip to document

Diphenhydramine MED CARD

Med cards for prenatal and postpartum.
Course

Maternal Child Nursing (NUR 104)

13 Documents
Students shared 13 documents in this course
Academic year: 2022/2023
Uploaded by:
Anonymous Student
This document has been uploaded by a student, just like you, who decided to remain anonymous.
Technische Universiteit Delft

Comments

Please sign in or register to post comments.

Preview text

MEDICATION CARD – LILIAN THIMOTTI

POSTPARTUM

DIPHENHYDRAMINE BENADRYL

GENERIC NAME TRADE NAME

CLASSIFICATION

Therapeutic: Competes for H 1 -receptor sites on effector cells, thus blocking histamine release.

Pharmacologic: ANTIHISTAMINE; H1-RECEPTOR ANTAGONIST Pregnancy Category: C INDICATIONS Temporary symptomatic relief of various allergic conditions and to treat or prevent motion sickness, vertigo, and reactions to blood or plasma in susceptible patients. Also used in anaphylaxis as adjunct to epinephrine and other standard measures after acute symptoms have been controlled; in treatment of parkinsonism and drug-induced extrapyramidal reactions; as a nonnarcotic cough suppressant; as a sedative-hypnotic; and for treatment of intractable insomnia. DOSAGE/RANGE Route & Dosage Allergy Symptoms, Antiparkinsonism, Motion Sickness, Nighttime Sedation Adult: PO 25–50 mg t.i. or q.i. (max: 300 mg/d) IV/IM 10–50 mg q4–6h (max: 400 mg/d) Child: PO/IV/IM 2–6 y, 6 mg q4–6h (max: 300 mg/24 h); 6–12 y, 12–25 mg q4–6h (max: 300 mg/ h). Nonproductive Cough Adult: PO 25 mg q4–6h (max: 100 mg/d) Child: PO 2–6 y, 6 mg q4–6h (max: 25 mg/24 h); 6–12 y, 12 mg q4–6h (max: 50 mg/24 h) SIDE EFFECTS CNS: Drowsiness, dizziness, headache, fatigue, disturbed coordination, tingling, heaviness and weakness of hands, tremors, euphoria, nervousness, restlessness, insomnia; confusion; (especially in children): excitement, fever. CV: Palpitation, tachycardia, mild hypotension or hypertension, cardiovascular collapse. Special Senses: Tinnitus, vertigo, dry nose, throat, nasal stuffiness; blurred vision, diplopia, photosensitivity, dry eyes. GI: Dry mouth, nausea, epigastric distress, anorexia, vomiting, constipation, or diarrhea. Urogenital: Urinary frequency or retention, dysuria. Body as a Whole: Hypersensitivity (skin rash, urticaria, photosensitivity, anaphylactic shock). Respiratory: Thickened bronchial secretions, wheezing, sensation of chest tightness_._

NURSING CONSIDERATIONS

Assessment & Drug Effects

Monitor cardiovascular status especially with pre-existing cardiovascular disease. Monitor for adverse effects especially in children and the older adult. Supervise ambulation and use side-rails as necessary. Drowsiness is most prominent during the first few days of therapy and often disappears with continued therapy. Older adults are especially likely to manifest dizziness, sedation, and hypotension. Patient & Family Education

Do not use alcohol and other CNS depressants because of the possible additive CNS depressant effects with concurrent use. Do not drive or engage in other potentially hazardous activities until the response to drug is known. Increase fluid intake, if not contraindicated; drug has an atropine-like drying effect (thickens bronchial secretions) that may make expectoration difficult. Do not breast feed while taking this drug.

Was this document helpful?

Diphenhydramine MED CARD

Course: Maternal Child Nursing (NUR 104)

13 Documents
Students shared 13 documents in this course
Was this document helpful?
MEDICATION CARD – LILIAN THIMOTTI
POSTPARTUM
DIPHENHYDRAMINE BENADRYL
GENERIC NAME TRADE NAME
CLASSIFICATION
Therapeutic: Competes for H1-receptor sites on effector cells, thus blocking histamine release.
Pharmacologic: ANTIHISTAMINE; H1-RECEPTOR ANTAGONIST
Pregnancy Category: C
INDICATIONS Temporary symptomatic relief of various allergic conditions and to treat or prevent motion
sickness, vertigo, and reactions to blood or plasma in susceptible patients. Also used in anaphylaxis as
adjunct to epinephrine and other standard measures after acute symptoms have been controlled; in
treatment of parkinsonism and drug-induced extrapyramidal reactions; as a nonnarcotic cough
suppressant; as a sedative-hypnotic; and for treatment of intractable insomnia.
DOSAGE/RANGE
Route & Dosage
Allergy Symptoms, Antiparkinsonism, Motion Sickness, Nighttime Sedation
Adult: PO 25–50 mg t.i.d. or q.i.d. (max: 300 mg/d) IV/IM 10–50 mg q4–6h (max: 400 mg/d)
Child: PO/IV/IM 2–6 y, 6.25 mg q4–6h (max: 300 mg/24 h); 6–12 y, 12.5–25 mg q4–6h (max: 300 mg/24
h).
Nonproductive Cough
Adult: PO 25 mg q4–6h (max: 100 mg/d)
Child: PO 2–6 y, 6.25 mg q4–6h (max: 25 mg/24 h); 6–12 y, 12.5 mg q4–6h (max: 50 mg/24 h)
SIDE EFFECTS
CNS: Drowsiness, dizziness, headache, fatigue, disturbed coordination, tingling, heaviness and weakness
of hands, tremors, euphoria, nervousness, restlessness, insomnia; confusion; (especially in children):
excitement, fever. CV: Palpitation, tachycardia, mild hypotension or hypertension, cardiovascular
collapse. Special Senses: Tinnitus, vertigo, dry nose, throat, nasal stuffiness; blurred vision, diplopia,
photosensitivity, dry eyes. GI: Dry mouth, nausea, epigastric distress, anorexia, vomiting, constipation, or
diarrhea. Urogenital: Urinary frequency or retention, dysuria. Body as a Whole: Hypersensitivity (skin
rash, urticaria, photosensitivity, anaphylactic shock). Respiratory: Thickened bronchial secretions,
wheezing, sensation of chest tightness.